Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal ...